Gigantol, a bibenzyl from Dendrobium draconis, inhibits the migratory behavior of non-small cell lung cancer cells.
暂无分享,去创建一个
[1] B. Sritularak,et al. Effects of artonin e on migration and invasion capabilities of human lung cancer cells. , 2013, Anticancer research.
[2] V. Pongrakhananon,et al. Long-Term Nitric Oxide Exposure Enhances Lung Cancer Cell Migration , 2013, BioMed research international.
[3] E. Gerner,et al. Caveolin‐1 is a novel regulator of K‐RAS‐dependent migration in colon carcinogenesis , 2013, International journal of cancer.
[4] Chiung-Chyi Shen,et al. Luteolin inhibits migration of human glioblastoma U-87 MG and T98G cells through downregulation of Cdc42 expression and PI3K/AKT activity , 2013, Molecular Biology Reports.
[5] B. Sritularak,et al. Moscatilin Inhibits Lung Cancer Cell Motility and Invasion via Suppression of Endogenous Reactive Oxygen Species , 2013, BioMed research international.
[6] V. Pongrakhananon,et al. Ouabain downregulates Mcl-1 and sensitizes lung cancer cells to TRAIL-induced apoptosis. , 2013, American journal of physiology. Cell physiology.
[7] Richard T. Jaspers,et al. Attenuated Increase in Maximal Force of Rat Medial Gastrocnemius Muscle after Concurrent Peak Power and Endurance Training , 2013, BioMed research international.
[8] Jian Luo,et al. Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1. , 2013, Journal of the National Cancer Institute.
[9] A. Jemal,et al. Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.
[10] E. Salazar,et al. Role of LOXs and COX-2 on FAK activation and cell migration induced by linoleic acid in MDA-MB-231 breast cancer cells , 2012, Cellular Oncology.
[11] Qingyong Chen,et al. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines. , 2012, International journal of oncology.
[12] John Condeelis,et al. Directed cell invasion and migration during metastasis. , 2012, Current opinion in cell biology.
[13] P. Chanvorachote,et al. Roles of caveolin-1 on anoikis resistance in non small cell lung cancer. , 2012, International journal of physiology, pathophysiology and pharmacology.
[14] Johanna Ivaska,et al. Filopodia and adhesion in cancer cell motility , 2011, Cell adhesion & migration.
[15] J. Guan,et al. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. , 2011, Advanced drug delivery reviews.
[16] B. Sritularak,et al. A new phenanthrenequinone from Dendrobium draconis , 2011, Journal of Asian natural products research.
[17] Y. Okamoto,et al. Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma. , 2010, International journal of oncology.
[18] Liying Wang,et al. Regulation of Lung Cancer Cell Migration and Invasion by Reactive Oxygen Species and Caveolin-1* , 2010, The Journal of Biological Chemistry.
[19] N. Asai,et al. Girding for migratory cues: roles of the Akt substrate Girdin in cancer progression and angiogenesis , 2010, Cancer science.
[20] T. Thompson,et al. Caveolin-1 Promotes Autoregulatory, Akt-Mediated Induction of Cancer-Promoting Growth Factors in Prostate Cancer Cells , 2009, Molecular Cancer Research.
[21] D. Schlaepfer,et al. Focal adhesion kinase: switching between GAPs and GEFs in the regulation of cell motility. , 2009, Current opinion in cell biology.
[22] A. Toker,et al. Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. , 2009, Cellular signalling.
[23] A. Ridley,et al. Phosphoinositide 3‐kinases in cell migration , 2009, Biology of the cell.
[24] L. Machesky. Lamellipodia and filopodia in metastasis and invasion , 2008, FEBS letters.
[25] Y. Liu,et al. Cytotoxic phenolics from Bulbophyllum odoratissimum , 2008 .
[26] Ji-Yeon Kim,et al. Gigantol isolated from the whole plants of Cymbidium goeringii inhibits the LPS-induced iNOS and COX-2 expression via NF-kappaB inactivation in RAW 264.7 macrophages cells. , 2006, Planta medica.
[27] G. Christofori,et al. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. , 2006, Cancer cell.
[28] Neil O. Carragher,et al. The role of focal-adhesion kinase in cancer — a new therapeutic opportunity , 2005, Nature Reviews Cancer.
[29] B. Dahlbäck,et al. C1‐TEN is a negative regulator of the Akt/PKB signal transduction pathway and inhibits cell survival, proliferation, and migration , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] D. Alessi,et al. Regulation of Akt/PKB Ser473 phosphorylation. , 2005, Molecular cell.
[31] Kerstin Lang,et al. Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. , 2004, The Lancet. Oncology.
[32] Sun-Ja Kim,et al. Increased expression of caveolin‐1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma , 2004, BJU international.
[33] C. Beaudry,et al. Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis , 2003, Journal of Cell Science.
[34] Kenneth M. Yamada,et al. Phosphatases in cell–matrix adhesion and migration , 2003, Nature Reviews Molecular Cell Biology.
[35] Pan‐Chyr Yang,et al. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. , 2002, The American journal of pathology.
[36] N. Masuyama,et al. Akt mediates Rac/Cdc42-regulated cell motility in growth factor-stimulated cells and in invasive PTEN knockout cells , 2001, Current Biology.
[37] G. Qin,et al. Chemical constituents from Dendrobium densiflorum. , 2001, Phytochemistry.
[38] C. Rinker-Schaeffer,et al. What defines a useful marker of metastasis in human cancer? , 1999, Journal of the National Cancer Institute.
[39] D. Schlaepfer,et al. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. , 1999, Journal of cell science.
[40] K. Pienta,et al. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. , 1995, Journal of the National Cancer Institute.